Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001365880 | SCV001562165 | uncertain significance | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2020-01-27 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with FOXP3-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with glutamine at codon 146 of the FOXP3 protein (p.Arg146Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. |